Braunstein ED, Croft LB, Halperin JL, Liao SL. Improved scoring system for the electrocardiographic diagnosis of left ventricular hypertrophy. World J Cardiol 2019; 11(3): 94-102 [PMID: 31040932 DOI: 10.4330/wjc.v11.i3.94]
Corresponding Author of This Article
Steve L. Liao, MD, Assistant Professor, Division of Cardiology, Mount Sinai Medical Center, 1176 5th Avenue, New York, NY 10029, United States. steve.liao@mountsinai.org
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Retrospective Cohort Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. Mar 26, 2019; 11(3): 94-102 Published online Mar 26, 2019. doi: 10.4330/wjc.v11.i3.94
Table 1 Patient characteristics
Characteristic - no. (%) unless noted
Derivation cohort (n = 5486)
Validation cohort (n = 910)
Age (mean ± SD)
59.1 ± 15.8
58.6 ± 15.2
18-29
265 (4.8)
30 (3.3)
30-39
408 (7.4)
91 (10.0)
40-49
708 (12.9)
105 (11.5)
50-59
1295 (23.6)
224 (24.6)
60-69
1358 (24.8)
242 (26.6)
70 +
1452 (26.5)
218 (24.0)
Male sex
2869 (52.3)
448 (49.2)
Body mass index
mean ± SD
28.0 ± 6.6
28.5 ± 6.5
Median (range)
26.9 (12.9-75.2)
27.5 (15.8-66.1)
Left ventricular mass by echocardiogram
mean ± SD
167.2 ± 62.1
173.3 ± 64.8
Median (intraquartile range)
155.4 (123.3-200.4)
163.0 (124.1-205.0)
Left ventricular hypertrophy present by echocardiogram
333 (6.1)
80 (8.6)
Time between echocardiogram and electrocardiogram in days (mean, intraquartile range)
6.7 (0-13)
5.9 (0-11)
Table 2 Multivariate logistic regression analysis for left ventricular hypertrophy
Characteristic
Wald Chi-Square
P value
Q-wave amplitude in V3
19.3
P < 0.0001
R-wave amplitude in V6
39.7
P < 0.0001
S-wave amplitude in V3
135
P < 0.0001
QRS Duration
115.4
P < 0.0001
Discordant R-axis and T-axis (difference ≤ 75 or > 75)
14.6
P = 0.0001
Maximum (positive deflection) T-wave amplitude in V6
38.5
P < 0.0001
Maximum P'-wave amplitude in V1
18.5
P < 0.0001
P-wave peak amplitude in V6
0.19
P = 0.659
Weight
0.008
P = 0.927
Height
25.2
P < 0.0001
Sex
6.3
P = 0.012
Age
0.03
P = 0.864
Table 3 Components of the electrocardiographic diagnostic score for left ventricular hypertrophy
Criteria
Number of points
Sum of R-wave amplitude in V6 + S-wave amplitude in V3 + Q-wave amplitude in V3 > 4.0 mV in males and 3.2 mV in females
1
QRS duration > 100 ms
1
Absence of positive component of T-wave in V6 (maximum T-wave amplitude < 0) when overall QRS vector in V6 positive (i.e., R-wave larger than S-wave)
1
Discordant limb lead R- and T-wave axis (R- minus T-wave axis ≤ 75 or > 75 degrees)
0.5
Amplitude of negative terminal p-wave deflection in V1 greater than amplitude of positive deflection
0.5
Table 4 Multivariate logistic regression analysis for left ventricular hypertrophy stratified by sex
Male (n = 2869)
Female (n = 2617)
Characteristic
Wald Chi-Square
P value
Wald Chi-Square
P value
Q-wave amplitude in V3
14.7
P = 0.0001
5.0
P = 0.025
R-wave amplitude in V6
25.5
P < 0.0001
10.0
P = 0.001
S-wave amplitude in V3
77.0
p < 0.0001
53.6
P < 0.0001
QRS Duration
62.2
P < 0.0001
51.2
P < 0.0001
Discordant R-axis and T-axis (difference ≤ 75 or > 75)
17.8
p < 0.0001
0.63
P = 0.426
Maximum (positive deflection) T-wave amplitude in V6
16.0
P < 0.0001
26.1
P < 0.0001
Maximum P'-wave amplitude in V1
9.4
P = 0.002
4.6
P = 0.031
P-wave peak amplitude in V6
1.0
P = 0.314
3.5
P = 0.061
Weight
0.50
P = 0.477
0.9
P = 0.340
Height
6.8
P = 0.009
21.8
P < 0.0001
Age
1.4
P = 0.245
1.06
P = 0.303
Table 5 Sensitivity, specificity, and positive and negative predictive values of selected electrocardiographic criteria for left ventricular hypertrophy
Derivation cohort
Validation cohort
Criteria
Cutoff
Sensitivity (95% CI)
Specificity (95% CI)
PPV
NPV
Sensitivity
Specificity
Derived Criteria
1.5 points
67.9 (62.6-72.9)
81.4 (80.3-82.4)
19.0
97.5
62.5
83.2
""
2 points
42.3 (37.0-47.7)
93.0 (92.3-93.7)
28.2
96.2
37.5
93.4
""
2.5 points
30.0 (25.2-35.3)
96.6 (96.1-97.1)
37.6
95.6
30.0
96.8
Cornell
-
37.8 (32.6-43.1)
92.3 (91.6-93.0)
24.1
95.8
36.2
90.3
Sokolow-Lyon
-
16.5 (12.5-20.5)
95.9 (95.4-96.5)
20.7
94.7
20.0
96.3
Cornell Product
55.0 (49.6-60.3)
88.3 (87.5-89.2)
23.3
96.8
53.8
88.1
Sokolow-Lyon Product
22.5 (18.0-27.0)
95.9 (95.3-96.4)
26.0
95.0
23.8
95.6
Gubner-Ungerleider
27.0 (22.3-31.8)
88.9 (88.0-89.8)
13.6
95.0
27.5
87.7
Sum-of-12-Lead
57.4 (51.9-62.7)
76.1 (74.9-77.3)
13.4
96.5
57.5
77.1
Romhilt-Estes
5 points
35.4 (30.3-40.8)
94.4 (93.7-95.0)
26.2
95.8
35.0
95.0
""
4 points
51.1 (45.5-56.5)
88.2 (87.3-89.0)
21.8
96.5
57.5
90.0
Framingham-adjusted Cornell
42.3 (37.0-47.7)
90.1 (89.3-90.9)
21.7
96.0
51.3
87.6
R-wave amplitude in aVL
1.1 mV
20.1 (16.0-24.8)
92.6 (91.8-93.3)
14.9
94.7
21.3
92.1
Peguero-Lo Presti
24.9 (20.3-29.6)
94.7 (94.1-95.3)
23.3
95.1
26.3
93.5
Citation: Braunstein ED, Croft LB, Halperin JL, Liao SL. Improved scoring system for the electrocardiographic diagnosis of left ventricular hypertrophy. World J Cardiol 2019; 11(3): 94-102